This work is licensed under the Creative Commons Attribution 4.0 International License.
Bader F, Manla Y, Atallah B, Starling RC. Heart failure and COVID-19. Heart Fail Rev 2021; 26(1):1–10.BaderFManlaYAtallahBStarlingRCHeart failure and COVID-19202126111010.1007/s10741-020-10008-2738312232720082Search in Google Scholar
Citu IM, Citu C, Gorun F, Neamtu R, Motoc A, Burlea B, et al. Using the NYHA classification as forecasting tool for hospital readmission and mortality in heart failure patients with COVID-19. J Clin Med 2022; 11(5):1382.CituIMCituCGorunFNeamtuRMotocABurleaBUsing the NYHA classification as forecasting tool for hospital readmission and mortality in heart failure patients with COVID-192022115138210.3390/jcm11051382891085935268473Search in Google Scholar
Coronavirus COVID-19 România. 2022. Available from: https://covid19.geo-spatial.org/. Accessed 10/04/2022.2022Available from: https://covid19.geo-spatial.org/. Accessed 10/04/2022.Search in Google Scholar
Laza R, Lazureanu VE, Musta VF, Nicolescu ND, Vernic C, Tudor A, et al. COVID-19 Independent risk factors for unfavorable disease progression: a cross-sectional study from Romania. Intl J Gen Med 2022; 15:2025–36.LazaRLazureanuVEMustaVFNicolescuNDVernicCTudorACOVID-19 Independent risk factors for unfavorable disease progression: a cross-sectional study from Romania20221520253610.2147/IJGM.S350920Search in Google Scholar
Chioncel O, Tatu-Chitoiu G, Christodorescu R, Coman IM, Deleanu D, Vinereanu D, et al. Characteristics of patients with heart failure from Romania enrolled in-ESC-HF Long-Term (ESC-HF-LT) Registry. Romanian J Cardiol 2015;25(4).ChioncelOTatu-ChitoiuGChristodorescuRComanIMDeleanuDVinereanuDCharacteristics of patients with heart failure from Romania enrolled in-ESC-HF Long-Term (ESC-HF-LT) Registry2015254Search in Google Scholar
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021; 42(36): 3599–726.McDonaghTAMetraMAdamoMGardnerRSBaumbachABöhmM2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC20214236359972610.1016/j.rec.2022.05.00535636830Search in Google Scholar
Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Gutierrez EJ, et al. Effect of heart failure on the outcome of COVID-19—a meta analysis and systematic review. Am J Emerg Med 2021; 46: 204–11.YonasEAlwiIPranataRHuangILimMAGutierrezEJEffect of heart failure on the outcome of COVID-19—a meta analysis and systematic review2021462041110.1016/j.ajem.2020.07.009734731633071085Search in Google Scholar
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020; 109(5):531–8.LiBYangJZhaoFZhiLWangXLiuLPrevalence and impact of cardiovascular metabolic diseases on COVID-19 in China20201095531810.1007/s00392-020-01626-9708793532161990Search in Google Scholar
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020; 323(16):1612–4.ArentzMYimEKlaffLLokhandwalaSRiedoFXChongMCharacteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State2020323161612410.1001/jama.2020.4326708276332191259Search in Google Scholar
Beale AL, Meyer P, Marwick TH, Lam CS, Kaye DM. Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation 2018; 138(2):198–205.BealeALMeyerPMarwickTHLamCSKayeDMSex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction2018138219820510.1161/CIRCULATIONAHA.118.03427129986961Search in Google Scholar
Popa AM, Savca M, Dogot M, Romaniuc I, Caproș N. Cardiovascular comorbidities—risk factors of death in COVID-19 patients. Romanian J Cardiol Suppl 2020: 99–100.PopaAMSavcaMDogotMRomaniucICaproșNCardiovascular comorbidities—risk factors of death in COVID-19 patients202099100Search in Google Scholar
Wang M, Zhang H, He Y, Qin C, Liu X, Liu M, et al. Association between ischemic stroke and COVID-19 in China: a population-based retrospective study. Front Med 2021; 8.WangMZhangHHeYQinCLiuXLiuMAssociation between ischemic stroke and COVID-19 in China: a population-based retrospective study2021810.3389/fmed.2021.792487889895935265632Search in Google Scholar
Nalleballe K, Siddamreddy S, Sheng S, Dandu V, Arulprakash N, Kovvuru S, et al. Coronavirus disease 2019 in patients with prior ischemic stroke. Cureus 2020; 12(9).NalleballeKSiddamreddySShengSDanduVArulprakashNKovvuruSCoronavirus disease 2019 in patients with prior ischemic stroke202012910.7759/cureus.10231753587233042672Search in Google Scholar
Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr: Clin Res Rev 2020; 14(3):247–50.BansalMCardiovascular disease and COVID-1920201432475010.1016/j.dsx.2020.03.013710266232247212Search in Google Scholar
DeFilippis EM, Reza N, Donald E, Givertz MM, Lindenfeld J, Jessup M. Considerations for heart failure care during the COVID-19 pandemic. JACC: Heart Fail 2020; 8(8):681–91.DeFilippisEMRezaNDonaldEGivertzMMLindenfeldJJessupMConsiderations for heart failure care during the COVID-19 pandemic2020886819110.1016/j.jchf.2020.05.006726677732493638Search in Google Scholar